Expand NVAX Menu
NVAX MENU

NVAX Stock Summary and Trading Ideas (Novavax | NASDAQ:NVAX)

Charts for Today's Stock Price and Implied Volatility in Novavax

18-Apr-2024

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for NVAX by Theoretical Edge and Win Rates

Sentiment

Trading Statistics

Key Ratios

Novavax (NVAX) Frequently Asked Questions

What does Novavax do?

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The Company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from Europe.

What symbol and exchange does Novavax stock trade?

Novavax trades on the NASDAQ stock market under the symbol NVAX.

What is Novavax stock price doing today?

As of April 18, 2024, NVAX stock price was flat at $3.89 with 2,752,151 million shares trading.

What is Novavax's Beta?

NVAX has a beta of 1.33, meaning it tends to be more sensitive to market movements. NVAX has a correlation of 0.06 to the broad based SPY ETF.

How much is Novavax worth?

NVAX has a market cap of $462.09 million. This is considered a Small Cap stock.

How much money does Novavax make?

Last quarter Novavax reported $291 million in Revenue and -$1.47 earnings per share. This fell short of revenue expectation by $-30 million and missed earnings estimates by -$1.02.

What is the highest and lowest price Novavax traded in the last 3 year period?

In the last 3 years, NVAX stock traded as high as $277.80 and as low as $3.53.

What are the top ETFs holding Novavax?

The top ETF exchange traded funds that NVAX belongs to (by Net Assets): XBI, VTI, VB, IWM, VXF.

Is Novavax (NVAX) a good investment?

NVAX has underperformed the market in the last year with a price return of -58.9% while the SPY ETF gained +22.3%. NVAX has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -7.5% and -14.3%, respectively, while the SPY returned +6.1% and -3.8%, respectively.

What is the support and resistance for Novavax (NVAX) stock price?

NVAX support price is $3.75 and resistance is $4.03 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NVAX stock will trade within this expected range on the day.